Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 18/20 | 1.00 |
| ▸ | HTR1A | P08908 | 5/20 | 0.77 |
| ▸ | HTR2A | P28223 | 5/20 | 0.77 |
| ▸ | DRD3 | P35462 | 5/20 | 0.68 |
| ▸ | DRD4 | P21917 | 4/20 | 0.68 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.68 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.68 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.68 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.68 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.68 |
| ▸ | DRD1 | P21728 | 2/20 | 0.68 |
| ▸ | DRD5 | P21918 | 2/20 | 0.68 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.68 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.68 |
| ▸ | HTR1D | P28221 | 2/20 | 0.68 |
| ▸ | HTR1B | P28222 | 2/20 | 0.68 |
| ▸ | HTR2C | P28335 | 2/20 | 0.68 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.68 |
| ▸ | HTR7 | P34969 | 2/20 | 0.68 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30552363 | 1.00 | DRD2 (1.00) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL8423 | 1.00 | DRD2 (1.00) | DRD2HTR1AHTR2ADRD3DRD4 | |
| Hydrochloric Acid SCHEMBL29365523 | 0.99 | DRD2 (0.98) | DRD2HTR1AHTR2ADRD3DRD4 | |
| Hydrochloric Acid SCHEMBL29923538 | 0.99 | DRD2 (0.98) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL30964304 | 0.99 | DRD2 (0.98) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL14587005 | 0.97 | DRD2 (0.94) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL251904 | 0.96 | DRD2 (1.00) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL253673 | 0.93 | DRD2 (1.00) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL13532797 | 0.93 | DRD2 (0.87) | DRD2HTR1AHTR2ADRD3DRD4 | |
| SCHEMBL14188956 | 0.90 | DRD2 (0.82) | DRD2HTR1AHTR2ADRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4221512-B1 | COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE | DECIMA DIAGNOSTICS LLC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20240024310-A1 | CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS | OTSUKA PHARMA CO LTD (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20230407369-A1 | COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE | Decima Diagnostics, LLC | 2023-12-21 | — | — | US | disclosed |
| EP-4267138-A1 | PRODRUGS OF PHARMACEUTICAL AGENTS | Axelyf ehf. (IS) | 2023-11-01 | — | — | EP | disclosed |
| EP-4221512-A1 | COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE | Decima Diagnostics, LLC (US) | 2023-08-09 | — | — | EP | disclosed |
| CN-111812218-B | Method for simultaneously detecting concentration of multiple antipsychotic drugs in serum | 南京品生医学检验实验室有限公司 | 2022-11-18 | — | — | CN | disclosed |
| US-20220276234-A1 | POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION | Decima Diagnostics, LLC | 2022-09-01 | — | — | US | disclosed |
| WO-2022140705-A1 | PRODRUGS OF PHARMACEUTICAL AGENTS | ALMARSSON ORN (US) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022072467-A1 | COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE | DECIMADX, LLC (US) | 2022-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024310-A1 | CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS | DRD2, CHRNA6, GABRA6 | DRD2 1/4885HTR1A 79/4885HTR2A 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.